Cargando…
Headache Education by E-Learning Through Social Networking Services (Social Media)
INTRODUCTION: Headache is a common public health problem, but its burden could be avoided by raising headache awareness and the appropriate use of acute medication and prophylactic medication. Few reports on raising headache awareness in the general public have been reported, and there are no report...
Autores principales: | Katsuki, Masahito, Nanri, Maiko, Miyakoshi, Yuki, Gobo, Shuto, Koh, Akihito, Kawamura, Shin, Tachikawa, Senju, Matsukawa, Ryo, Kashiwagi, Kenta, Matsuo, Mitsuhiro, Yamagishi, Fuminori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625744/ https://www.ncbi.nlm.nih.gov/pubmed/37933331 http://dx.doi.org/10.2147/JHL.S432132 |
Ejemplares similares
-
Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases
por: Kashiwagi, Kenta, et al.
Publicado: (2023) -
One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention
por: Katsuki, Masahito, et al.
Publicado: (2023) -
Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old
por: Katsuki, Masahito, et al.
Publicado: (2023) -
Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023) -
Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
por: Kawamura, Shin, et al.
Publicado: (2022)